发明名称 DIAGNOSIS AND RISK STRATIFICATION BY MEANS OF THE NOVEL MARKER CT-PROADM
摘要 The invention relates to a novel diagnostic marker CT-proADM (C-terminal fragment of preproADM, SEQ ID No. 1) for diagnosing and/or stratifying the risk of diseases. Also disclosed is a method for diagnosing and/or stratifying the risk of diseases, particularly cardiovascular diseases, cardiac insufficiency, and infections and/or inflammations of the lungs and respiratory tract. In said method, the CT-proADM (SEQ ID No. 1) marker, or a partial peptide of fragment thereof, or said marker contained in a marker combination (panel, cluster) is determined in a patient who is to be examined. The invention further relates to a diagnostic apparatus as well as a kit for carrying out said method.
申请公布号 US2015011017(A1) 申请公布日期 2015.01.08
申请号 US201414478639 申请日期 2014.09.05
申请人 BRAHMS GmbH 发明人 BERGMANN ANDREAS;Struck Joachim
分类号 G01N33/68;C07K14/47 主分类号 G01N33/68
代理机构 代理人
主权项 1. Diagnostic marker consisting of CT-proADM (SEQ ID No. 1), or partial peptides or fragments thereof.
地址 Hennigsdorf DE